Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMRVNS vs ProQuad in Healthy Children 4-6 Years
NCT05630846Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2022
- Primary completion
- Jun 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 5
01
Overview
A Phase 2 trial of MMRVNS in measles, mumps, rubella, chickenpox, sponsored by GSK. Started Dec 2022; status: completed.
02
Drugs
MMRVNS
03
Conditions
measlesmumpsrubellachickenpox
Beyond the preview
Go deeper on NCT05630846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05630846.